Medical Advisory Board

Some Of The Best Experts In The World

The Foundation’s Medical Advisory Board includes experts in the diagnosis, treatment and research of GBS and CIDP, many of whom have authored textbooks on the disorder, and is considered to be the “think-tank” of GBS and CIDP disorders.

- MEDICAL ADVISORY BOARD -
Arthur K. Asbury, MD
Richard J. Barohn, MD
Mark J. Brown, MD
David Cornblath, MD
Marinos C. Dalakas, MD
Peter D. Donofrio, MD
Jonathan Goldstein, MD
Clifton L. Gooch, MD
Kenneth C. Gorson, MD
Michael C. Graves, MD
Angelika F. Hahn, MD
Hans-Peter Hartung, MD
Thomas L. Hedge, MD
Professor Richard A. C. Hughes
Jonathan Katz, MD
Carol Lee Koski, MD
Richard A. Lewis, MD
Robert Lisak, MD
Gareth J. Parry, MD
David S. Saperstein, MD
Kazim A. Sheikh, MD
John T. Sladky, MD
Joel S. Steinberg, MD, PhD
Pieter A. van Doorn, MD
Professor Hugh J. Willison

  • Centers of Excellence

  • Connect With Us

  • Topics of Interest

    rdday

    Walk & Roll for GBS-CIDP - Greater Delaware Valley

    Saturday, June 8, 2013 - Wilson Farm Park

    The Walk and Roll for GBS-CIDP is the new signature walk fundraising campaign of the GBS-CIDP Foundation International. This national Walk is designed to support the thousands of families forced to face the challenges caused by CIDP, GBS and its variants. Register or sponsor a participant today.

    CIDP: Diagnosis and Treatment

    Richard J. Barohn, MD, Professor and Chair Department of Neurology at the University of Kansas Medical Center, and a member of the GBS/CIDP Foundation International Medical Advisory Board gave a presentation to the Harris County Neurological Society in November – "CIDP: Diagnosis and Treatment". Sit back and watch the video (an hour long) and hear from one of the leading experts on CIDP in the world. Share it with your neurologist.

    cslbehring

    The PATH Study – CIDP Treatment with Subcutaneous Immunoglobulin

    CSL Behring is currently recruiting CIDP patients for a clinical trial. Click above link for full access to view article.

Subject: Question: